Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV)

Historical Holders from Q2 2021 to Q3 2025

Symbol
ELEV
CUSIP
28623U101
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
62.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2K
Holdings value
$720
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-60
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 7% $1.24M 4.44M BVF PARTNERS L P/IL Mar 31, 2025
TANG CAPITAL MANAGEMENT LLC 5% -49.9% $1.18M -$1.11M 3.12M -48.5% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
VANGUARD GROUP INC 4.41% $731K 2.61M The Vanguard Group Dec 31, 2024
GOLDMAN SACHS GROUP INC 2.8% $471K 1.68M THE GOLDMAN SACHS GROUP, INC. Dec 31, 2024
BlackRock, Inc. 0.6% -96% $122K -$922K 369K -88.3% BlackRock, Inc. Jun 30, 2025

Institutional Holders of Elevation Oncology, Inc. - Common stock, par value $0.0001 per share (ELEV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2K $720 -$10.8M $0.36 1
2025 Q2 29.5M $10.8M -$793K $0.37 63
2025 Q1 33.8M $8.76M -$4.44M $0.26 70
2024 Q4 40M $22.5M -$3.75M $0.56 70
2024 Q3 45.9M $27.6M -$42.3M $0.60 68
2024 Q2 52.1M $140M +$17.1M $2.70 79
2024 Q1 44M $226M +$110M $5.13 61
2023 Q4 25.8M $13.9M -$1.44M $0.54 31
2023 Q3 28M $18.6M -$4.59M $0.66 40
2023 Q2 31.5M $47.9M +$22.1M $1.52 37
2023 Q1 16.2M $30.8M +$3.71M $1.90 26
2022 Q4 14.4M $13.7M +$99K $0.95 25
2022 Q3 14.3M $16.1M -$1.53M $1.13 20
2022 Q2 15M $21M -$7.07M $1.40 21
2022 Q1 18.7M $47.2M +$631K $2.52 27
2021 Q4 18.3M $110M -$3.12M $6.02 34
2021 Q3 15.9M $123M -$8.12M $7.79 21
2021 Q2 16.2M $217M +$217M $13.57 36